Medicinal cannabis in Australia: the missing links

Jennifer H Martin and Yvonne A Bonomo
Med J Aust 2016; 204 (10): 371-373. || doi: 10.5694/mja16.00234
Published online: 6 June 2016

Cultivation of cannabis for medicinal or scientific purposes needs considered management before it is rolled out as a therapeutic good

Since the publication in the Journal last year of a perspective on cannabis that stated: “Australia is behind the times on the medicinal use of cannabis”,1 there appears to have been a palpable change in community attitudes around cannabis as medicine.2-4 This has occurred alongside anecdotal reports from people with intractable illnesses who have had symptomatic benefit with cannabis.5 Palliative care specialists have acknowledged a potential role for medicinal cannabis in their specialty.6 Internationally, the scene is also changing. For example, the Netherlands Office of Medicinal Cannabis enables dispensation through pharmacies after purchase from a contracted company, which also exports to other European countries.7 In the United States, 23 states and Washington, DC, have legalised marijuana in some form, mostly for medicinal purposes, since June 2015.8

  • Jennifer H Martin1,2
  • Yvonne A Bonomo3

  • 1 University of Newcastle, Newcastle, NSW
  • 2 Hunter New England Local Health District, Newcastle, NSW
  • 3 St Vincent's Health, Melbourne, VIC

Competing interests:

Jennifer Martin is involved in the NSW Health-funded medicinal cannabis trials and Yvonne Bonomo is leading cannabis research and education programs in Victoria.


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Responses are now closed for this article.